Two sickle cell disease researchers will share a $3 million Breakthrough Prize for discoveries that changed the treatment ...

Etavopivat improved hemoglobin levels and reduced pain crises in a Phase 3 sickle cell disease trial, supporting potential ...

Newly diagnosed with DVT and a pulmonary embolism, columnist Michelle Harlan finds herself in an unfamiliar relationship with ...

People with sickle cell disease in Africa are less likely to use common treatments and may report lower burden, a global ...

The isolation of chronic disease isn't just about being physically alone; it's also emotional and social, says columnist ...

Bias in sickle cell care may be tied to opioid stigma, with patients more often described negatively in medical records, a ...

Having a remote job has been a game-changer for me as someone with sickle cell disease. I’m better able to manage my health — no rushed mornings, cold commutes, or physical strain. I can plan my day ...

Through a project aimed at building empathy and understanding among clinicians about sickle cell disease (SCD)-related pain episodes, a team of nurses in Chicago has helped standardize emergency care ...

In the U.S., having sickle cell disease (SCD) continues to place a heavy clinical burden on patients, who often require multiple medications, frequent blood transfusions, and the use of opioids to ...

Researchers from the University of Illinois Chicago (UIC) have received $3.78 million in federal funding to evaluate whether a diabetes medication can slow kidney damage in people with sickle cell ...

Higher levels of fetal hemoglobin (HbF) seem to protect people with sickle cell disease (SCD) by reducing the risk of lung problems, such as pulmonary hypertension, and delaying bone damage, at least ...

As part of my advocacy, I frequently deliver keynote speeches and participate in panel discussions, and I’m often asked a particular question: “Is sickle cell disease a disability?” My answer is ...